X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accesswire.com/853164/radius-announces-presentation-of-data-on-tymlos-abaloparatide-at-the-world-congress-on-osteoporosis-osteoarthritis-and-musculoskeletal-diseases
https://www.prnewswire.com/news-releases/apotex-corp-launches-teriparatide-injectable-for-osteoporosis-treatment-in-the-united-states-301995274.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211097
https://www.ema.europa.eu/en/documents/overview/kauliv-epar-medicine-overview_en.pdf
https://www.ema.europa.eu/en/documents/overview/kauliv-epar-medicine-overview_en.pdf
https://www.globenewswire.com/news-release/2022/10/06/2529359/0/en/Entera-Bio-Announces-FDA-Agreement-for-a-Single-Phase-3-Clinical-Trial-to-Support-an-NDA-for-EB613-for-the-Treatment-of-Osteoporosis.html
https://www.globenewswire.com/news-release/2022/08/10/2496211/0/en/Rani-Therapeutics-Announces-Positive-Topline-Results-from-Phase-1-Study-of-RT-102-in-Osteoporosis.html
https://www.ema.europa.eu/en/documents/overview/sondelbay-epar-medicine-overview_en.pdf
https://born2invest.com/articles/grunenthal-deal-teva-market-teriparatide/
https://www.bigmoleculewatch.com/2020/08/28/cadila-pharmaceuticals-announces-launch-of-fourth-biosimilar-in-two-months/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+GoodwinProcter-BigMoleculeWatchBlog+%28Big+Molecule+Watch+Blog+%7C+Goodwin%29
https://www.moneycontrol.com/news/business/companies/strides-re-enters-injectable-biz-to-take-controlling-stake-in-stelis-biopharma-4459361.html
http://www.pharmatimes.com/news/richter_launches_forsteo_biosimilar_in_eu_1298480
https://www.prnewswire.com/news-releases/richter-launched-terrosa-its-biosimilar-teriparatide-across-europe-300904178.html
https://endpts.com/amgen-prices-bone-builder-evenity-at-21900-year-to-compete-on-convenience-not-cost/
https://globenewswire.com/news-release/2019/02/28/1744291/0/en/Pfenex-and-Alvogen-Expand-Development-and-Commercialization-Collaboration-for-PF708-a-Therapeutic-Equivalent-Candidate-to-Forteo-Forsteo-to-the-EU-MENA-and-ROW.html
https://www.fiercebiotech.com/biotech/hubert-chen-resigns-as-pfenex-cmo-ahead-nda?utm_source=internal&utm_medium=rss
https://endpts.com/amgen-ucb-are-back-pitching-once-rejected-osteoporosis-drug-romo-to-the-fda-but-big-hurdles-lie-ahead/
https://www.pharmacompass.com/pdf/news/shire-pharmaceuticals-ireland-ltd-natpar-parathyroid-hormone-receives-approval-in-europe-1493277719.pdf
Market Place
Share 
